Last updated: April 30, 2024
Sponsor: Universiti Sains Malaysia
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetes Mellitus Types I And Ii
Diabetes And Hypertension
Diabetes Mellitus, Type 2
Treatment
Gelafundin
Clinical Study ID
NCT06180824
InsulinUSM
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient admitted to ICU Hospital USM regardless of whether patient intubated or not.
- Adult patient 18 years old and above.
- 2 consecutive blood sugar more than 10 mmol/L including patient with diabeticketoacidosis and hyperosmolar hyperglycaemic state.
- Within 12 hours from admission.
- Patient not in high inotropic support and with APACHE II score less than 17.
Exclusion
Exclusion Criteria:
- Pregnancy.
- History of any allergic from previous gelafundin infusion or known patient to haveallergic towards gelafundin (allergic card, or information from relatives)
- Post cardiac arrest or prolonged resuscitation.
- Patient with cardiogenic shock.
Study Design
Total Participants: 74
Treatment Group(s): 1
Primary Treatment: Gelafundin
Phase:
Study Start date:
January 09, 2024
Estimated Completion Date:
December 31, 2024
Connect with a study center
Mohd Zulfakar Mazlan
Kota Bharu, Kelantan 16150
MalaysiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.